This review included two Cochrane reviews, 14 meta-analyses and 15 trials. Ketamine was studied versus placebo, versus other comparators and as an anesthetic adjuvant before electroconvulsive therapy. In 14 publications, ketamine provided a rapid antidepressant effect with a maximum efficacy reached at 24 hrs. Its effect lasted for 1-2 weeks after infusion, but a longer-term effect is little reported. Ketamine does not seem to improve depressive symptoms at the end of electroconvulsive sessions. Safety and tolerability profiles with ketamine at low single dose are generally good in depressed patients.
- Alexandrine Corriger, Gisèle Pickering
- August 2019
Excerpts from the publication
Read more
Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa
Sarah-Catherine Rodan, Phillip Aouad, Iain S McGregor, Sarah Maguire
June 2021
Ketamine and depression: a narrative review
Alexandrine Corriger, Gisèle Pickering
August 2019
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron, Charlie J. Benson, Brian C. DeFelice, Oliver Fiehn, and David E. Olson
March 2019